The observation that intestinal NF-κB signalling is altered by CLA in vivo is in keeping with earlier work using cancer cell lines (Peng et al., 2014), but it is the first demonstration that macrolides alter this signalling pathway in either untransformed enteroids or gastrointestinal mucosae in vivo. The gene discussed is NFKB1; the disease is cancer.